EPISODE · Jul 21, 2025 · 35 MIN
HIV Treatment Updates: Counseling, Adherence, and Clinical Pearls
from CEimpact Podcast
HIV treatment has evolved significantly, offering streamlined regimens and improved patient outcomes. This episode will discuss the latest antiretroviral therapy (ART) guidelines, highlighting preferred regimens, key pharmacologic considerations, and practical counseling strategies for pharmacists. Tune in to enhance your clinical knowledge and play a pivotal role in optimizing care for individuals living with HIV. Joshua Davis Kinsey, PharmDVP, EducationCEimpactRachel Maynard, PharmDLead EditorPyrlsJoshua Davis Kinsey and Rachel Maynard have no relevant financial relationships to disclose. BONUS: With this episode, you also get exclusive, FREE access to beautifully designed clinical charts and practice resources from our friends at Pyrls, that you can use in your everyday practice. Click the links below to access these practical tools:HIV PharmacotherapyHIV MedicationsAnd more! CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:If you are already enrolled in this course, click here to redeem your credit. To purchase this episode and claim your CPE credit, click here. CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify current guideline-recommended antiretroviral therapy (ART) regimens and their key components.2. Describe important counseling points for pharmacists supporting patients on HIV treatment, including adherence, side effects, and drug interactions. 0.05 CEU/0.5 HrUAN: 0107-0000-25-245-H02-PInitial release date: 7/21/2025Expiration date: 7/21/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram
NOW PLAYING
HIV Treatment Updates: Counseling, Adherence, and Clinical Pearls
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m